Quay Pharma are unique in both the academic standing of our scientists, and our drive to discover the most elegant and effective response, not the first or most obvious, to every challenge of drug delivery and dosage.Read More
Maireadh is the Chief Executive Officer of Quay. She brings more than 16 years experience of business development in an international marketing environment, dealing with the supply of analytical tools and equipment as well as formulation technologies for the pharmaceutical industries. Maireadh’s previous roles include two years as VP with responsibility for Pharmaceutical Business Development at Teraview and eight years at Colorcon managing their EMEA film coating and excipients business.Contact
Mike has over 20 years’ experience in drug product development. For over 15 years he has been responsible for development activities at Quay Pharma. During this period Mike has overseen over 200 non-sterile development projects; predominantly taking NCE’s through to first in human studies and beyond. His background is in formulation science with a PhD in liquisolid dosage forms and is cited as an inventor on multiple oral formulation patents.Contact
Ryan, with 30 years knowledge of drug development and manufacturing for small molecules and biologicals, Ryan brings a wealth of knowledge to Quay. Overseeing strategic new development projects at Quay, Ryan has been instrumental in Quays leading position in the formulation development and clinical manufacture of live biotherapeutics.
Melanie Ackerley is Quay Pharma’s Head of Quality and has been a releasing QP since 2016. Melanie has a degree in Microbiology and Diploma in Quality Assurance and has worked for 20 years in QA, QC and Validation roles in Pharma covering biologics, steriles, blow fill seal and solid dose. Melanie has held previous roles as Head of Quality, Head of QC and Site Microbiologist at a mix of large Pharma companies, as a consultant and in contract manufacturing.Contact
Barbara is CIMA qualified, but having started in marketing, brings a innovative commercial skill set to our finance team. With extensive experience in acquiring and setting up new companies, Barbara is now deeply involved in helping establish Quays first facilities in the US at Hudson, New Hampshire.Contact
Chris has recently joined Quay with 20+ years experience in pharmaceutical manufacturing and site management gained from working in UK based pharmaceutical companies and CDMO’s. Leading the Quay House facilities Chris is working with the teams to establish new ways of working that improves efficiency and communication across the site for effective customer project delivery.Contact